Showing results (151-160 of 281) with videos related to

Sort By:
Pageof 29
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|May 26, 1999
Pulsed electron-nuclear double resonance (ENDOR) at 140 GHzM Bennati, C T Farrar, J A Bryant, et al.
The Journal of Surgical Research|November 23, 2018
Inpatient Pain Medication Administration: Understanding the Process and Its DelaysJasmine Hwang, Gabriel K Koo, Saemi E De Palm, et al.
Gastroenterology|December 14, 2005
Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugsJames D Lewis, Stephen E Kimmel, A Russell Localio, et al.
Regional Anesthesia and Pain Medicine|September 30, 2019
Prospective cohort study examining the use of regional anesthesia for early pain management after combat-related extremity injuryRollin M Gallagher, Rosemary C Polomano, Nicholas A Giordano, et al.
Statistics in Medicine|July 26, 2012
The design and conduct of clinical trials to limit missing dataR J Little, M L Cohen, K Dickersin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 10, 2025
Optimization of CEST MRI Reporter Protein Design Using Cation-Pi NetworksDavid E Korenchan, Ethan J French, Emerenziana Runco, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|September 8, 2009
Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled TrialDebbie L Cohen, Leanne T Bloedon, Rand L Rothman, et al.
The American Journal of Cardiology|January 28, 2010
Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intoleranceSteven C Halbert, Benjamin French, Ram Y Gordon, et al.
Nature Reviews. Clinical Oncology|August 13, 2014
Vessel caliber--a potential MRI biomarker of tumour response in clinical trialsKyrre E Emblem, Christian T Farrar, Elizabeth R Gerstner, et al.
Pharmacoepidemiology and Drug Safety|January 12, 2008
Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicityJames D Lewis, Brian L Strom, A Russell Localio, et al.
Pageof 29